| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/28/2007 | EP1765311A2 Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| 03/28/2007 | EP1545552B1 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 03/28/2007 | EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 03/28/2007 | EP1474441B1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c) |
| 03/28/2007 | EP1453532A4 Taojiks as modifiers of the beta-catenin pathway and methods of use |
| 03/28/2007 | EP1443931B1 Ocular iontophoretic device for delivering methotrexate based medicaments and use thereof to treat neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities |
| 03/28/2007 | EP1414470B1 Micronutrient phosphates as dietary and health supplements |
| 03/28/2007 | EP1335733B1 Treatment of osteoporosis |
| 03/28/2007 | EP1331933B1 Tiagabine for the treatment of diabetic neuropathy |
| 03/28/2007 | EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 03/28/2007 | EP1259239B1 USE OF 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLO[1,5-b]PYRIDAZINE FOR THE TREATMENT OF NON-ULCERATIVE DYSPEPSIA |
| 03/28/2007 | EP1228071B1 Pharmaceutically active isoindoline derivatives |
| 03/28/2007 | EP1082416B1 Poly(adp-ribose)polymerase gene |
| 03/28/2007 | EP0991426B2 Method for transferring nucleic acid into the striated muscle |
| 03/28/2007 | EP0927163B1 Preparation of 1-butyl-4-piperidinylmethylamine |
| 03/28/2007 | CN1938325A Synthetic membrane anchors |
| 03/28/2007 | CN1938318A Process for producing flavone C glycoside derivatives |
| 03/28/2007 | CN1938317A Adiponectin increasing agent |
| 03/28/2007 | CN1938041A Influenza virus-infection inhibitor |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 03/28/2007 | CN1935811A 3-aryl-5,6-substituted thienopyrimidine-4-carbonyl-2-mercaptoacetonitrile, and its synthesizing method and use |
| 03/28/2007 | CN1935277A Preparation for the prophylaxis of restenosis |
| 03/28/2007 | CN1935255A Slow-release gamma-interferon nano capsule, and its preparing method and use |
| 03/28/2007 | CN1935200A Kusnezoff aconite leaf extract and its preparing method |
| 03/28/2007 | CN1935181A Animal medicament with tonifying qi and strengthening exterior, pusdraining and toxin-expelling, and its preparing method |
| 03/28/2007 | CN1935173A Animal medicament with expelling toxin bycooling, purging liver to brighten vision and its preparing method |
| 03/28/2007 | CN1935163A Animal medicament with expelling toxin by cooling and cooling blood to stop diarrhea and its preparing method |
| 03/28/2007 | CN1935156A Remedy |
| 03/28/2007 | CN1935155A Remedy |
| 03/28/2007 | CN1935134A Combination comprising combretastatin and anticancer agents |
| 03/28/2007 | CN1935122A Methylene blue lyophilized preparation, and its preparing method and use |
| 03/28/2007 | CN1307421C Method and compositions for overcoming resistance to biologic and chemotherapy |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1307157C Novel compounds |
| 03/28/2007 | CN1307147C 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 03/28/2007 | CN1306963C Remedy for diseases caused by IL-6 production |
| 03/28/2007 | CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/27/2007 | US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196199 Phenoxypropylamine compounds |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196105 Which suppresses I-kappa-B-alpha phosphorylation through inhibition kinase activity and downregulating NF-kappa-B; antiproliferative agents |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196098 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/27/2007 | US7196096 Substituted amines of spirofuropyridines useful in therapy |
| 03/27/2007 | US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196084 Cdc25 phosphatase inhibitors |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196077 Tachykinin antagonists |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7196068 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 03/27/2007 | US7195914 Composition and method for treatment of hypertriglyceridemia |
| 03/27/2007 | US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 03/27/2007 | US7195896 Complementary adenoviral vector systems and cell lines |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | US7195769 Bioavailability |
| 03/27/2007 | US7195675 Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2370244C Piperidine derivatives |
| 03/27/2007 | CA2303810C Antistress agents and functional foods |
| 03/27/2007 | CA2219651C Antifungal composition |
| 03/27/2007 | CA2200084C Use of aromatic halides for treating mammalian cell proliferation |
| 03/27/2007 | CA2180841C 1-aminoindan derivatives and compositions thereof |
| 03/27/2007 | CA2168879C Skin patches and methods for providing testosterone |
| 03/27/2007 | CA2141555C Morphogenic protein soluble complex and composition thereof |
| 03/27/2007 | CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives |
| 03/22/2007 | WO2007032566A1 Hematopoietic stem cell proliferator |
| 03/22/2007 | WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032536A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032445A1 Protein kinase inhibitors |
| 03/22/2007 | WO2007032371A1 Oxindole derivative as feeding control agent |
| 03/22/2007 | WO2007032362A1 Substituted cycloalkene derivative |
| 03/22/2007 | WO2006114703A3 Method of administration of (1s,s2) -1- (4 -hydroxyphenyl) -2- (4-hydr0xy-4-phenylpiperidin-1-yl) -1- propano (traxoprodil) |
| 03/22/2007 | WO2006104989A3 Altered antibody fc regions and uses thereof |
| 03/22/2007 | WO2006096800A3 Immunogenic t cell targets in autoimmune hepatitis and methods of use |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066677 serine proteases such as dipeptidyl peptidases inhibitor; antidiabetic agent; metabolic disorders, hyperglycosemia, hyperglycosemia, gastrointestinal, viral, autoimmune, dermatological, psychosomatic, depressive, and neuropsychiatric disorders, obesity, psoriasis, intestinal distress, arthritis |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066564 Sulfotransferase inhibitor |
| 03/22/2007 | US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |